Investing
The company has received 12 US FDA approvals.
The company offers services like sperm cryopreservation, fertility testing, testosterone treatments, and vasectomies.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The company will use the funds to scale its technology, expand into new biomarker applications, and advance real-time hydration and metabolic health monitoring.
Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.
GC Wealth is aimed at founders and entrepreneurs within GC Famiglia's global community of entrepreneurs and CEOs connected to General Catalyst.
The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.
The virtual opioid use disorder company reached profitability in Q4 2024, and expanded its team with the appointments of a chief operating officer and chief financial officer.